Suresh Senan

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC.

C. Faivre-Finn, S. Senan, D. Raben, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

S. Peters, S. Senan, D. Tan, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. G. Levra, Johan Vansteenkiste, Sanne A.E. Peters, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.

G. Scagliotti, W. De Neve, J. V. van Meerbeeck, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.